Abstract:Programmed cell death (PCD) is an essential part of organismal development and plays fundamental roles in host defense against pathogens and the maintenance of homeostasis. However, excess activation of PCD pathways has proven to be detrimental and can drive disease. Additionally, resistance to PCD can also contribute to disease development. Modulation of PCD, therefore, has great therapeutic potential in a wide range of diseases, including infectious, neurodegenerative, autoinflammatory, and metabolic diseases and cancer. Nevertheless, manipulation of cell death and inflammation for therapeutic intervention is a delicate process, highly specific to the context of the disease of interest, making the selection of the appropriate target molecule crucially important. Several PCD pathways are associated with innate immunity, including pyroptosis, apoptosis, necroptosis, and PANoptosis, which is defined as an inflammatory PCD pathway with key features of pyroptosis, apoptosis, and/or necroptosis that cannot be accounted for by any of these three PCD pathways alone. All of these PCD pathways are regulated by upstream sensors and signaling cascades that assemble multimeric complexes to serve as activation platforms for downstream molecules; these sensors and signaling molecules provide attractive target points for therapeutic intervention. Here, we discuss the molecular mechanisms of innate immune-mediated cell death in health and disease, with a particular focus on the molecules putatively involved in the formation of the PANoptosome and the induction of inflammatory cell death. Further, we discuss the implications and feasibility of targeting these molecules to improve disease outcomes, as well as current clinical approaches.

Control of Cell Death in Health and Disease

Necroptosis in Inflammatory Bowel Disease and Other Intestinal Diseases

Dying cells fan the flames of inflammation

Cell death-mediated cytokine release and its therapeutic implications

Programming inflammatory cell death for therapy

The therapeutic potential of targeting regulated non-apoptotic cell death

Programmed necrosis in the cross talk of cell death and inflammation.

Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis

Programmed Cell Death and Its Role in Inflammation

Using Small Molecules to Dissect Non‐apoptotic Programmed Cell Death: Necroptosis, Ferroptosis, and Pyroptosis

Plasma Membrane Pores Drive Inflammatory Cell Death

Programmed cell death as a defence against infection

Necroptosis: a regulated inflammatory mode of cell death

The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death

Cell death: a review of the major forms of apoptosis, necrosis and autophagy

Implications of inflammatory cell death-PANoptosis in health and disease

A comparative study of apoptosis, pyroptosis, necroptosis, and PANoptosis components in mouse and human cells

15 Cell Death

Regulated necrosis, a proinflammatory cell death, potentially counteracts pathogenic infections

Not to be and how not to be: the questions of Tregs controlled by RIPK1

The molecular machinery of regulated cell death